Fresenius Medical Care Corporation
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more
Fresenius Medical Care Corporation (FMS) - Total Assets
Latest total assets as of December 2025: $31.00 Billion USD
Based on the latest financial reports, Fresenius Medical Care Corporation (FMS) holds total assets worth $31.00 Billion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Fresenius Medical Care Corporation - Total Assets Trend (1998–2025)
This chart illustrates how Fresenius Medical Care Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Fresenius Medical Care Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
Fresenius Medical Care Corporation's total assets of $31.00 Billion consist of 25.5% current assets and 74.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.2% |
| Accounts Receivable | $3.14 Billion | 10.1% |
| Inventory | $2.14 Billion | 6.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $14.83 Billion | 47.8% |
| Goodwill | $13.57 Billion | 43.8% |
Asset Composition Trend (1998–2025)
This chart illustrates how Fresenius Medical Care Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Fresenius Medical Care Corporation's current assets represent 25.5% of total assets in 2025, an increase from 25.1% in 1998.
- Cash Position: Cash and equivalents constituted 5.2% of total assets in 2025, up from 0.6% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 90.0% of total assets, an increase from 61.0% in 1998.
- Asset Diversification: The largest asset category is intangible assets at 47.8% of total assets.
Fresenius Medical Care Corporation Competitors by Total Assets
Key competitors of Fresenius Medical Care Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Fresenius Medical Care Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Fresenius Medical Care Corporation generates 0.63x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Fresenius Medical Care Corporation generates $ 3.15 in net profit.
Fresenius Medical Care Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.26 | 1.40 | 1.08 |
| Quick Ratio | 0.92 | 1.03 | 0.80 |
| Cash Ratio | 0.00 | 0.21 | 0.00 |
| Working Capital | $1.65 Billion | $ 2.26 Billion | $ 546.44 Million |
Fresenius Medical Care Corporation - Advanced Valuation Insights
This section examines the relationship between Fresenius Medical Care Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.82 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | -7.6% |
| Total Assets | $31.00 Billion |
| Market Capitalization | $4.49 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Fresenius Medical Care Corporation's assets below their book value (0.14 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Fresenius Medical Care Corporation's assets decreased by 7.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Fresenius Medical Care Corporation (1998–2025)
The table below shows the annual total assets of Fresenius Medical Care Corporation from 1998 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $31.00 Billion | -7.64% |
| 2024-12-31 | $33.57 Billion | -1.07% |
| 2023-12-31 | $33.93 Billion | -5.10% |
| 2022-12-31 | $35.75 Billion | +4.04% |
| 2021-12-31 | $34.37 Billion | +8.45% |
| 2020-12-31 | $31.69 Billion | -3.78% |
| 2019-12-31 | $32.93 Billion | +25.50% |
| 2018-12-31 | $26.24 Billion | +9.23% |
| 2017-12-31 | $24.03 Billion | -5.80% |
| 2016-12-31 | $25.50 Billion | +9.20% |
| 2015-12-31 | $23.35 Billion | +11.89% |
| 2014-12-31 | $20.87 Billion | +24.66% |
| 2013-12-31 | $16.74 Billion | -0.82% |
| 2012-12-31 | $16.88 Billion | +12.02% |
| 2011-12-31 | $15.07 Billion | +17.25% |
| 2010-12-31 | $12.85 Billion | +16.40% |
| 2009-12-31 | $11.04 Billion | +3.03% |
| 2008-12-31 | $10.72 Billion | +10.27% |
| 2007-12-31 | $9.72 Billion | -1.67% |
| 2006-12-31 | $9.88 Billion | +46.64% |
| 2005-12-31 | $6.74 Billion | +14.76% |
| 2004-12-31 | $5.87 Billion | -1.42% |
| 2003-12-31 | $5.96 Billion | -7.79% |
| 2002-12-31 | $6.46 Billion | -11.77% |
| 2001-12-31 | $7.32 Billion | +15.04% |
| 2000-12-31 | $6.37 Billion | +11.36% |
| 1999-12-31 | $5.72 Billion | +18.05% |
| 1998-12-31 | $4.84 Billion | -- |